H.C. Wainwright Initiates Structure Therapeutics(GPCR.US) With Buy Rating, Announces Target Price $80

Moomoo NewsDec 20 13:31 ET · Ratings

Promising Potential of Structure Therapeutics' ACCG-2671 Drives Buy Rating

TipRanksDec 20 13:00 ET · Ratings

Buy Rating for Structure Therapeutics, Inc. Driven by Innovative Drug Development and Promising Obesity Treatment Platform

TipRanksDec 20 12:45 ET · Ratings

Express News | Shares of Viking Therapeutics up 4.2%, Amgen up 1%

ReutersDec 20 09:34 ET

Express News | Weight Loss Drug Developers Rise Intraday Trading After Novo Nordisk's Obesity Drug Cagrisema Achieves Lower Weight Loss Than Expected

ReutersDec 20 06:03 ET

Structure Therapeutics Price Target Maintained With a $80.00/Share by HC Wainwright & Co.

Dow JonesDec 19 12:07 ET · Ratings